1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Vascular Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dol, F; Herbert, JM; Laplace, MC; Mares, AM | 1 |
| Evangelou, AM | 1 |
| Barnathan, ES; Buck, CA; Cines, DB; Hug, BA; Konkle, BA; Loscalzo, J; McCrae, KR; McEver, RP; Pober, JS; Pollak, ES; Schmidt, AM; Schwartz, BS; Stern, DM; Wick, TM; Zimmerman, GA | 1 |
| Broussas, M; Cornillet, P; Hézard, N; Nguyen, P; Potron, G | 1 |
| Beilin, LJ; Kendrew, PJ; Strophair, JM; Sturm, MJ; Taylor, RR; Vandongen, R | 1 |
| Benveniste, J; Chignard, M | 1 |
4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Vascular Diseases
| Article | Year |
|---|---|
Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arteriosclerosis; Blood Vessels; Coronary Disease; Cytokines; Endothelium, Vascular; Humans; Phospholipases A; Platelet Activating Factor; Vascular Diseases; Vasculitis | 1994 |
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Topics: Animals; Arteriosclerosis; Blood Cells; Blood Coagulation; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Endothelial Growth Factors; Endothelins; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Female; Fibrinolysis; Fibroblast Growth Factor 2; Hemodynamics; Humans; Inflammation; Lymphokines; Male; Mice; Neovascularization, Physiologic; Nitric Oxide; Platelet Activating Factor; Pre-Eclampsia; Pregnancy; Thrombosis; Umbilical Veins; Vascular Diseases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
[Modulators of leukocytic functions].
Topics: Animals; Cyclic AMP; Free Radicals; Humans; Leukocytes; Monocytes; Neutrophils; Platelet Activating Factor; Vascular Diseases | 1998 |
A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Humans; Hypersensitivity; Kidney Diseases; Platelet Activating Factor; Rabbits; Vascular Diseases | 1985 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Vascular Diseases
| Article | Year |
|---|---|
Platelet-activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury.
Topics: Animals; Aorta; Cell Division; Endothelium, Vascular; Hyperplasia; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thiazoles; Vascular Diseases | 1995 |
Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis; Cell Aggregation; Collagen; Humans; Male; Middle Aged; Platelet Activating Factor; Smoking; Thromboxane B2; Vascular Diseases | 1989 |